1 / 54

Acute Glomerulonephritis

Acute Glomerulonephritis. Tutorial Med Course 441. Prof Jamal Alwakeel. Nephrology Division King Khalid University. 14 year old Saudi Male. c/o fever-headache for 10 days General malaise Dark urine x 3 days. HPI. Fever intermittent Muscular joint pain Urine character Edema

rasia
Download Presentation

Acute Glomerulonephritis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acute Glomerulonephritis Tutorial Med Course 441 Prof Jamal Alwakeel Nephrology DivisionKing Khalid University

  2. 14 year old Saudi Male • c/o fever-headache for 10 days • General malaise • Dark urine x 3 days

  3. HPI • Fever intermittent • Muscular joint pain • Urine character • Edema • No skin rash

  4. PH & Med • Antibiotic and NSAID • Social Hx • S. review • FH

  5. Examination • BP : 160/90 mmHg and • pulse rate: 120/min • Temperature : 39 ºC • Respiration: 25/min. pale • Look Sick • Puffiness in face • Head and neck • JVP

  6. Chest Examination • Normal percussion • Normal TVF • Normal breath sound • Vesicular breathing • S1 increase • S2 N • S3 positive • Pansystolic murmur • Radiation to axilla • Grade IIII

  7. Abd • Tend epigastic • Tend loins • BS +ve • CNS • Normal • M.S. /Normal

  8. Initial Diagnosis • Fever? Infection vs autoimmune Disease • Murmur ; M R vs VSD • HEAMATURIA Urine Sample with hematuria

  9. Initial Diagnosis Hematuria • Systemic • Hemolytic Anemia • Embolization • Anti-coagulant • Surgical • Stone • Tumor • Papillary • APKD • Medical • Acute kidney injury • Glomerulonephritis • Rapid pogressiveglomerulonephrtis • IgA Nephropathy

  10. Differential Diagnosis of Hematuria • ARF-AKI-ATN • Acute glomerulonephritis (post-infection) • RPGN • IgA • Hemolytic uremic syndrome • NSAID Hemolytic Anemia IgA Nephropathy Hemolytic uremic

  11. Investigation • WBC 15,000 cells/microliter • Hb – 100 g/L • Plat – 150 g/L • ESR 90 • PT normal • PPT normal Sec • BI normal Sec

  12. U&E • Scr - 210µmol/L • Urea – 20mmol/L • K – 6mmol/L • Na – 125 mmol/L • Ca – 1.9 mmol/L • Albumin – 28 g/L

  13. Urine Analysis • Many RBC • Red cell cast abscent • Protein – 1.2 g/24 hr

  14. U/S : kid size ENLARGE 12.2 cm

  15. Treatment • Patient receive ceftriaxone IV and IV fluid • TREAT HYPERKALEMIA

  16. Follow – up: • S Cr – 300 µmmol/L • JVP • Oliguria • Edema

  17. Investigations for Glomerulonephritis • Regular follow-up and U&E • Antistreptolysin O (ASO) • ANA, Anti-DNA • C3-C4 • ANCA (p,c) • HCV Antibody (HBsAg) • HIV • RF • Cryoglobulin • Anti-basement membrane anti-body (with lung hemorrhage

  18. Management • IV Lasix • Repeat urine analysis • RBC cast • Kidney biopsy : RPGN • Serology tesy : all negative • RF: -negative • Final diagnosis • Anti-glomerular basement membrane anti-bodies

  19. Glomerular Disease – Acute Glomerulonephritis • Post infectious glomerulonephritis • Group A Strep Infection • Infective endcarditis • Membranoproliferative glomerulonephritis: • Systemic lupus erythematosus • Hepatitis C virus • IgA Nephropathy (Buerger’s Disease) Rapidly progressive glomerulonephritis Type I RPGN (direct antibody) • Good Posture syndrome Type II RPGN (immune complex) • Post infectious • Systematic lupus erythematosus • Henoch – Schonleinpupura (IgA) Type III RPGN (pauci-immune) • Vasculitis (, Wegener granulomatosis; poiyarteritisnodosa-microscopic polyangitis)

  20. Complications of acute glomerulonephritis • Hypertension • Pulmonary edema • Hyperkalemia • Encephalopathy convulsion • Electrolyte disturbance • Pericaditis • Gastroentritis • Peptic ulcer

  21. Management of Glomerulonephritis • Treat the cause • Conservative management • Dialysis

  22. Acute post-infection glomerulonephritis • Often associated with group A • B-hemolytic streptococcal type 12 infection • Also staphylococcus or viruses

  23. Acute Glomerulonephritis • Symptoms occur 10-21 days after infection • Hematuria • Proteinuria (<1gm/24 hr) • Decreased GFR, oliguria • Hypertension • Edema around eyes, feet and ankles • Ascites or pleural effusion • Antistreptolysin O (ASO), Low C3, normal C4 • Kidney biopsy immune complexes and proliferation

  24. Proliferative GN-post streptococcal • This glomerulus is hypercellular and capillary loops are poorly defined • This is a type of proloferative glomerulonephritis known as post-streptococcal glomerulonephritis

  25. Post-streptococcal GN • Post-streptococcal glomerulonephritis is immunologically mediated, and the immune deposits are distributed in the capillary loops in a granular, bumpy pattern because of the focal nature of the deposition process

  26. Post-streptococcal glomerunephritis • Conservative Treatment (acute kidney injury • Improves 1 – 4 weeks, C3 normalizes in 1 – 3 months, hypertension improves 1 – 3 months, intermittent hematuria x 3 years • 99% complete recovery in children and 85% in adult

  27. IgA nephropathy (Buerger’s Disease) • Most common acute glomerulonephritis in US, South East Asia • Associated with H.S. Purpura • Upper respiratory (50%) in 1 – 2 days (synpharyngitichematuria) • Primary versus secondary (IBD, Liver disease, SLE, vasculitis) • 50% risk of CRF • Proteinuria, hypertension, renal insufficiency predict worse prognosis • 50% increase IgA, normal compliments TREATMENT OF CONSERVATIVE ACEi • HIGH RISK: patient prednisone and alkylating agent • Cyclophosphamide-azothroprim & ASA & ACEi & tosilectomy

  28. Rapid Progressive GN • Type I RPGN(direct antibody) • Good pasture syndrome • Type II RPGN(immune complex) • Post infectious • Systematic lupus erythematosus • Henoch-schonleinpurpura (IgA) • cryoglobulinemia • Type II (pauci-immune) • Vasculitis (, Wegener granulomatosis, microscopic polyangitis,poplyarteriesnodosa)

  29. Rapidly progressive GN • Develops over a period of days and weeks • Primarily adults in 50’s and 60’s • Progresses to renal failure in a few weeks or months • Hematuria is common, may see proteinuria, edema or hypertension

  30. Rapidly progressive (Crescentic) Glomerulonephritis • Morphology • Crescent formation • Crescents are formed by proliferation of parietal cells • Infiltrates of WBC’s & fibrin deposition in Bowman’s space • EM reveals focal ruptures in the GBM

  31. Goodpasture Syndrome • Antibody formation against pulmonary and glomerular capillary basement membranes • Damage glomerular basement membrane • Men – 20 to 30 years of age • Pulmonary hemorrhage and renal failure TREATMENT • Early treatment is essential • Pulse steroid (10 mg/kg/day for 3 – 5 days) • Cyclophosphamide • Plasmapheresis

  32. Goodpasture’s syndrome This immunoflourescence micrograph shows positivity with antibody to IgG has a smooth, diffuse, linear pattern that is characteristic for glomerular basement antibody with Goodpasture’s syndrome

  33. Microscopic Polyangitis • Necrotizing vasculitis of small – and medium – sized vessels in both the arterial and venous circulations • Frequently involves the lung and the kidney with typical complications of hemorrhage and glomerulonephritis • Usually positive p-ANCA (anti-myeloperoxidase) • Usually positive c-ANCA (ant-proteinase 3)

  34. Treatment Initial Therapy • Combination cyclophosphamide-corticosteroid therapy • Pulse methyl prednisone (10 mg/kg/day for 3-5 days) • A slow steroid taper, with the goal of reaching 20 mg of prednisone per day by the end of two months and an overall glucocorticoid course of between 6 and 9 months • Either daily oral or monthly intravenous cyclophosphamide

  35. Treatment Plasmapheresis • Severe manifestations of pumonary hemorrhage on presentation • Dialysis – dependent renal failure upon presentation • Concurrent anti-GBM antibodies

  36. Thank you…

More Related